TANG KEVIN C
Q3 2020 Form 13-F

CIK 0001178579 · Institutional investment manager
Holdings reported by TANG CAPITAL MANAGEMENT LLC since Q2 2013
$1.2M Reported Value Total
Reported value
$1.2M
Quarter over quarter
-4.1%
Holdings
2
Top-10 concentration
100.0%

Filing Structure

Holdings reported by

Key People

Named on the latest Form 13-F filing — not necessarily an owner
Kevin Tang
Individual

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2020 13F record

Q3 2020 13F filing summary

Q3 2020 Form 13F portfolio summary
Period of report September 30, 2020
Filed November 16, 2020
Form 13F-HR
Reported value $1.2M
Positions 2
Change in reported value -4.1%
New positions 0
Exited positions 0
Position turnover 0.0%
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2023 13F
Filed Nov 14, 2023
1 $783
Q2 2023 13F
Filed Aug 14, 2023
1 $882
Q1 2023 13F
Filed May 15, 2023
1 $1.1K
Q4 2022 13F
Filed Feb 14, 2023
1 $1.9K
Q3 2022 13F
Filed Nov 14, 2022
1 $3.0K
Q2 2022 13F
Filed Aug 15, 2022
2 $768.0K
Q1 2022 13F
Filed May 16, 2022
2 $1.0M
Q4 2021 13F
Filed Feb 14, 2022
2 $1.1M
Q3 2021 13F
Filed Nov 15, 2021
2 $966.0K
Q2 2021 13F
Filed Aug 16, 2021
2 $1.1M
Q1 2021 13F
Filed May 17, 2021
2 $1.1M
Q4 2020 13F
Filed Feb 16, 2021
2 $1.0M
Q3 2020 13F
Filed Nov 16, 2020
2 $1.2M
Q2 2020 13F
Filed Aug 14, 2020
2 $1.3M
Q1 2020 13F
Filed May 15, 2020
2 $1.3M
Q4 2019 13F
Filed Feb 14, 2020
2 $8.4M
Q3 2019 13F
Filed Nov 14, 2019
2 $2.8M
Q2 2019 13F
Filed Aug 14, 2019
2 $2.9M
Q1 2019 13F
Filed May 15, 2019
2 $2.5M

Top 2 holdings · Q3 2020

Largest Q3 2020 13F positions by reported value
# Holding Reported value % of portfolio
1 LJPC LA JOLLA PHARMACEUTICAL CO $967.0K 78.24%
2 HRTX HERON THERAPEUTICS INC $269.0K 21.76%

Values as reported on the Q3 2020 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings